Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
News Feed

XORTX Files New Provisional Patent to Diagnose and Treat Individuals Most at Risk of Polycystic Kidney Disease Progression

January 4, 2023 The Wall Street Analyzer Comments Off on XORTX Files New Provisional Patent to Diagnose and Treat Individuals Most at Risk of Polycystic Kidney Disease Progression

CALGARY, Alberta, Jan. 03, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to […]

News Feed

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

December 29, 2022 The Wall Street Analyzer Comments Off on Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

The AcQForce Flutter clinical study was submitted to the FDA as part of Acutus’ PMA submission for the AcQBlate Force Sensing Ablation Catheter […]

News Feed

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 The Wall Street Analyzer Comments Off on Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that […]

News Feed

21st Century Marketing Group Licenses Zerify Defender to Protect Confidential Client Data

December 19, 2022 The Wall Street Analyzer Comments Off on 21st Century Marketing Group Licenses Zerify Defender to Protect Confidential Client Data

EDISON, N.J., Dec. 19, 2022 (GLOBE NEWSWIRE) — Zerify Inc., (OTCQB: ZRFY), the 21-year-old cybersecurity company focused on secure video conferencing solutions, today announced that 21st Century Marketing Group has licensed Zerify Defender to protect confidential […]

News Feed

Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans

December 15, 2022 The Wall Street Analyzer Comments Off on Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans

ANN ARBOR, MI / ACCESSWIRE / December 15, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the […]